SCHEMBL6859308

SCHEMBL6859308

Cc1noc(C)c1-c1ccc(/C=C2/NC(=N)N(C)C2=O)o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.41
▸ GSK3A P49840 2/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ MAPT P10636 11/20 0.37
▸ ALDH1A1 P00352 10/20 0.37
▸ KDM4E B2RXH2 8/20 0.37
▸ KMT2A Q03164 8/20 0.37
▸ PKM P14618 7/20 0.37
▸ MEN1 O00255 6/20 0.37
▸ TDP1 Q9NUW8 6/20 0.37
▸ HTT P42858 2/20 0.37
▸ POLB P06746 4/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ CACNA1B Q00975 1/20 0.36
▸ APBA1 Q02410 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1115917 0.74 CLK1 (0.41) GSK3AGSK3BMAPTALDH1A1KDM4E
SCHEMBL1115919 0.74 CLK1 (0.41) GSK3AGSK3BMAPTALDH1A1KDM4E
SCHEMBL1116271 0.71 BRD4 (0.53) MAPTALDH1A1KDM4EKMT2APKM
SCHEMBL1116166 0.70 CA2 (0.38) GSK3AGSK3BMAPTALDH1A1KDM4E
SCHEMBL1116165 0.70 CA2 (0.38) GSK3AGSK3BMAPTALDH1A1KDM4E
SCHEMBL13056356 0.58 GSK3A (0.78) IDH1GSK3AGSK3BMAPTALDH1A1
SCHEMBL28747775 0.58 AR (0.49) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL14005636 0.57 AHR (0.73) IDH1MAPTALDH1A1KDM4EKMT2A
SCHEMBL2899566 0.56 MAPT (0.51) IDH1GSK3AGSK3BMAPTALDH1A1
SCHEMBL15980859 0.55 BRD4 (0.58) BRD4BRD2CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback